Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

✍ Scribed by Stanley B. Cohen; Robin K. Dore; Nancy E. Lane; Peter A. Ory; Charles G. Peterfy; John T. Sharp; Désirée van der Heijde; Lifen Zhou; Wayne Tsuji; Richard Newmark

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 160 KB
• Volume: 58
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.23417